Status:

COMPLETED

Intelligibility Assessment for Parkinson's Disease

Lead Sponsor:

Long Island University

Conditions:

Parkinson Disease

Eligibility:

All Genders

30-85 years

Phase:

NA

Brief Summary

The investigators aim at testing the efficacy of an app to measure sentence intelligibility in noise in speakers with Parkinson's disease and in healthy controls.

Detailed Description

Close to 90% of people with Parkinson's disease develop voice problems during the course of the disease. These problems lead to reduced intelligibility, which entails a subsequent reduction in social ...

Eligibility Criteria

Inclusion

  • Speakers with PD:
  • Have a medical diagnosis of Parkinson's disease
  • Have experienced changes in your voice (e.g., your voice has "lost its strength") and your voice is a current concern
  • Have not received individual speech therapy for the past 2 years (group therapy is ok)
  • Have a stable medication schedule
  • Have not received DBS (Deep Brain Stimulation)
  • Are a native speaker of American English

Exclusion

  • If criteria above are not met
  • Healthy controls:
  • Inclusion Criteria:
  • Be a native speaker of American English
  • Have no history of neurological impairment
  • Have no history of speech or language problems

Key Trial Info

Start Date :

April 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 4 2022

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT04829006

Start Date

April 1 2021

End Date

April 4 2022

Last Update

April 12 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Long Island University

Brooklyn, New York, United States, 11201